These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27010500)

  • 1. Design, synthesis and biological evaluation of N,N-3-phenyl-3-benzylaminopropanamide derivatives as novel cholesteryl ester transfer protein inhibitor.
    Zhao D; Xie H; Bai C; Liu C; Hao C; Zhao S; Yuan H; Luo C; Wang J; Lin B; Zheng J; Cheng M
    Bioorg Med Chem; 2016 Apr; 24(8):1589-97. PubMed ID: 27010500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel N,N-3-phenyl-3-benzylaminopropionanilides as potent inhibitors of cholesteryl ester transfer protein in vivo.
    Xie H; Li Y; Bai C; Wang R; Liu C; Hao C; Lin B; Cheng M; Zhao D
    Bioorg Med Chem; 2016 Apr; 24(8):1811-8. PubMed ID: 26993745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Biological Evaluation of N,N-Disubstituted-4-Arylthiazole-2-Methylamine Derivatives as Cholesteryl Ester Transfer Inhibitors.
    Wang X; Lin X; Xu X; Li W; Hao L; Liu C; Zhao D; Cheng M
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29112169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-based discovery of novel pentacyclic triterpenoid derivatives as cholesteryl ester transfer protein inhibitors.
    Chang Y; Zhou S; Li E; Zhao W; Ji Y; Wen X; Sun H; Yuan H
    Eur J Med Chem; 2017 Jan; 126():143-153. PubMed ID: 27750148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311).
    Qiao JX; Wang TC; Adam LP; Chen AY; Taylor DS; Yang RZ; Zhuang S; Sleph PG; Li JP; Li D; Yin X; Chang M; Chen XQ; Shen H; Li J; Smith D; Wu DR; Leith L; Harikrishnan LS; Kamau MG; Miller MM; Bilder D; Rampulla R; Li YX; Xu C; Lawrence RM; Poss MA; Levesque P; Gordon DA; Huang CS; Finlay HJ; Wexler RR; Salvati ME
    J Med Chem; 2015 Nov; 58(22):9010-26. PubMed ID: 26524347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of novel cholesteryl ester transfer protein inhibitors bearing a cycloalkene scaffold.
    Liu C; Luo C; Hao L; Wu Q; Xie H; Zhao S; Hao C; Zhao D; Cheng M
    Eur J Med Chem; 2016 Nov; 123():419-430. PubMed ID: 27490022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and SAR studies of ursolic acid 3β-ester derivatives as novel CETP inhibitors.
    Chen C; Sun R; Sun Y; Chen X; Li F; Wen X; Yuan H; Chen D
    Bioorg Med Chem Lett; 2020 Jan; 30(2):126824. PubMed ID: 31780304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors.
    Khalaf RA; Al-Rawashdeh S; Sabbah D; Abu Sheikha G
    Med Chem; 2017; 13(3):239-253. PubMed ID: 27823564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis and Biological Evaluation of N,N-Substituted Amine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors.
    Wang X; Hao L; Xu X; Li W; Liu C; Zhao D; Cheng M
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28972557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
    Chen D; Huang X; Zhou H; Luo H; Wang P; Chang Y; He X; Ni S; Shen Q; Cao G; Sun H; Wen X; Liu J
    Eur J Med Chem; 2017 Oct; 139():201-213. PubMed ID: 28802120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Biological Evaluation, and Molecular Modeling Study of Substituted Benzyl Benzamides as CETP Inhibitors.
    Abu Khalaf R; Sabbah D; Al-Shalabi E; Bishtawi S; Albadawi G; Abu Sheikha G
    Arch Pharm (Weinheim); 2017 Dec; 350(12):. PubMed ID: 29112287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a novel class of biphenyl CETP inhibitors.
    Lu Z; Napolitano JB; Theberge A; Ali A; Hammond ML; Tan E; Tong X; Xu SS; Latham MJ; Peterson LB; Anderson MS; Eveland SS; Guo Q; Hyland SA; Milot DP; Chen Y; Sparrow CP; Wright SD; Sinclair PJ
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7469-72. PubMed ID: 21041082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors.
    Wang A; Prouty CP; Pelton PD; Yong M; Demarest KT; Murray WV; Kuo GH
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1432-5. PubMed ID: 20089400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility.
    Kalgutkar AS; Frederick KS; Hatch HL; Ambler CM; Perry DA; Garigipati RS; Chang GC; Lefker BA; Clark RW; Morehouse LA; Francone O; Hu X
    Xenobiotica; 2014 Jul; 44(7):591-605. PubMed ID: 24380613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Inhibition of Cholesteryl Ester Transfer Protein by Small Molecule Inhibitors.
    Chirasani VR; Sankar R; Senapati S
    J Phys Chem B; 2016 Aug; 120(33):8254-63. PubMed ID: 27111423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Molecular Modeling and Biological Evaluation of Novel Trifluoromethyl Benzamides as Promising CETP Inhibitors.
    Abu Khalaf R; Abusaad A; Al-Nawaiseh B; Sabbah D; Albadawi G
    Curr Comput Aided Drug Des; 2024; 20(5):564-574. PubMed ID: 37165488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of (2R,alphaS)-3,4-dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)-phenyl]-alpha-(trifluoromethyl)-1(2H)-quinolineethanol as potent and orally active cholesteryl ester transfer protein inhibitor.
    Kuo GH; Rano T; Pelton P; Demarest KT; Gibbs AC; Murray WV; Damiano BP; Connelly MA
    J Med Chem; 2009 Mar; 52(6):1768-72. PubMed ID: 19236017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromanol derivatives--a novel class of CETP inhibitors.
    Vakalopoulos A; Schmeck C; Thutewohl M; Li V; Bischoff H; Lustig K; Weber O; Paulsen H; Elias H
    Bioorg Med Chem Lett; 2011 Jan; 21(1):488-91. PubMed ID: 21084191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2D and 3D QSAR models for identifying diphenylpyridylethanamine based inhibitors against cholesteryl ester transfer protein.
    Chen M; Yang X; Lai X; Gao Y
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4487-95. PubMed ID: 26346366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitors.
    Lu Z; Chen YH; Napolitano JB; Taylor G; Ali A; Hammond ML; Deng Q; Tan E; Tong X; Xu SS; Latham MJ; Peterson LB; Anderson MS; Eveland SS; Guo Q; Hyland SA; Milot DP; Chen Y; Sparrow CP; Wright SD; Sinclair PJ
    Bioorg Med Chem Lett; 2012 Jan; 22(1):199-203. PubMed ID: 22142541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.